OSU's kidney dialysis technology provider has added about $36m to close its initial public offering, its shares having more than doubled in price.
Outset Medical, the US-based dialysis technology producer advacing research from Oregon State University, closed its initial public offering at approximately $278m yesterday.
The company floated on Wednesday, issuing 8.95 million shares on the Nasdaq Global Select Market at $27 each to raise an initial $242m. The shares, already priced above the IPO’s $22 to $24 range, closed at $58.02 yesterday.
Joint lead book-running managers BofA Securities, Morgan Stanley and Goldman Sachs, and co-managers SVB Leerink and Stifel have…
